Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Lipocine stock

Learn how to easily invest in Lipocine stock.

Lipocine is a biotechnology business based in the US. Lipocine shares (LPCN) are listed on the NASDAQ and all prices are listed in US Dollars. Lipocine employs 17 staff and has a trailing 12-month revenue of around $16.6 million.

How to buy Lipocine stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – LPCN. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Lipocine stock price (NASDAQ: LPCN)

Use our graph to track the performance of LPCN stocks over time.

Lipocine shares at a glance

Information last updated 2023-02-02.
Latest market close$0.52
52-week range$0.36 - $1.89
50-day moving average $0.46
200-day moving average $0.63
Wall St. target price$3.67
PE ratio 13.0125
Dividend yield $0 (0%)
Earnings per share (TTM) $0.04

Buy Lipocine stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$10
FINDER EXCLUSIVE: Get $15
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Lipocine stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Lipocine price performance over time

Historical closes compared with the close of $0.521 from 2023-02-01

1 week (2023-01-26) 0.19%
1 month (2022-12-30) 30.97%
3 months (2022-11-02) 29.41%
6 months (2022-08-02) -34.05%
1 year (2022-02-01) -49.90%
2 years (2021-02-02) -69.53%
3 years (2020-01-31) 18.06%
5 years (2018-02-02) 1.33

Is Lipocine stock undervalued or overvalued?

Valuing Lipocine stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Lipocine's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Lipocine's P/E ratio

Lipocine's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Lipocine shares trade at around 13x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Lipocine's EBITDA

Lipocine's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 million.

The EBITDA is a measure of a Lipocine's overall financial performance and is widely used to measure a its profitability.

Lipocine financials

Revenue TTM $16.6 million
Operating margin TTM 19.45%
Gross profit TTM $16.1 million
Return on assets TTM 5.05%
Return on equity TTM 11.62%
Profit margin 24.69%
Book value $0.43
Market capitalisation $46.1 million

TTM: trailing 12 months

Lipocine share dividends

We're not expecting Lipocine to pay a dividend over the next 12 months.

Have Lipocine's shares ever split?

Lipocine's shares were split on a 1:100 basis on 24 July 2013. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lipocine shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Lipocine shares which in turn could have impacted Lipocine's share price.

Lipocine share price volatility

Over the last 12 months, Lipocine's shares have ranged in value from as little as $0.36 up to $1.89. A popular way to gauge a stock's volatility is its "beta".

LPCN.US volatility(beta: 0.78)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lipocine's is 0.7848. This would suggest that Lipocine's shares are less volatile than average (for this exchange).

Lipocine overview

Lipocine Inc. , a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that has completed Phase II clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis; LPCN 1111, an oral prodrug of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical trial in hypogonadal men; LPCN 1148, a novel prodrug of testosterone and testosterone laurate for the management of decompensated cirrhosis; LPCN 1154, an investigational new drug application to conduct a Phase 2 study in Postpartum depression; LPCN 2101 for women with epilepsy, which has completed pre-clinical study; and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. The company is headquartered in Salt Lake City, Utah. .

Frequently asked questions

What percentage of Lipocine is owned by insiders or institutions?
Currently 2.768% of Lipocine shares are held by insiders and 12.282% by institutions.
How many people work for Lipocine?
Latest data suggests 17 work at Lipocine.
When does the fiscal year end for Lipocine?
Lipocine's fiscal year ends in December.
Where is Lipocine based?
Lipocine's address is: 675 Arapeen Drive, Salt Lake City, UT, United States, 84108
What is Lipocine's ISIN number?
Lipocine's international securities identification number is: US53630X1046
What is Lipocine's CUSIP number?
Lipocine's Committee on Uniform Securities Identification Procedures number is: 53630X104

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site